Liu Yuntong. Exosomes derived from umbilical cord mesenchymal stem cells repair skull defect of osteoporosis rats: an experimental study[J]. Journal of chongqing medical university, 2023, 48(1): 18-23.
DOI:
Liu Yuntong. Exosomes derived from umbilical cord mesenchymal stem cells repair skull defect of osteoporosis rats: an experimental study[J]. Journal of chongqing medical university, 2023, 48(1): 18-23.DOI:
Exosomes derived from umbilical cord mesenchymal stem cells repair skull defect of osteoporosis rats: an experimental study
Objective: To explore the repairing effect of exosomes derived from human umbilical cord mesenchymal stem cells (HucMSCs) on the skull defect of osteoporosis rats. Methods: Isolation the exosomes from HucMSCs
the morphology and size of the exosomes were identified by transmission electron microscopy and nanoparticle tracking analysis
and the surface markers were identified by Western blot. Rat bone marrow mesenchymal stem cells (BMSCs) were isolated and their surface markers were identified by flow cytometry. Exosomes (control
20 μg/mL
40 μg/mL
60 μg/mL
80 μg/mL) were co-cultured with BMSCs
and the effects of different concentra-tions of exosomes on proliferation and early osteogenic differentiation of BMSCs were detected. Osteoporosis model was established by ovariectomy (OVX) in SD rats. Exosomes suspension was injected at the same time as the skull defect model was estab-lished. Eight weeks after operation
the rats were euthanized. micro-CT scanning and bone mass analysis was performed on the tissue of the operation area
and the healing of bone defect was observed under microscope after HE staining
so as to evaluate the repairing potential of exosomes from HucMSCs on the skull defect of osteoporosis rats. Results: The results of transmission electron microscope and nanoparticle tracking analysis showed that the shape and size of exosomes derived from HucMSCs met the requirements
and the expression of surface protein markers CD63 and CD81 were positive. The surface markers CD29
CD90 and CD45 of rats BMSCs were expressed as 99.86%
99.50% and 4.12% respectively
which accorded with the characteristics of mesenchymal stem cells. After co-culturing 60 μg/mL exosomes with BMSCs for 5 days
the cell viability was (127.782±7.184) % of the control group (P=0.001)
the expression of alkaline phosphatase (ALP) was (2.715±0.095) times of the control group (P=0.003)
and the expression of Runx family transcription factor 2 (Runx2) was (2.175±0.731) times of the control group (P=0.140). In the repair of an OVX-induced osteoporosis SD rat skull defect model
micro-CT showed that the exosome group had a significant increase in bone healing compared with the control group. The results of bone mass analysis showed that in the exosome group
the bone volume/tissue volume was (11.000±1.708) % (P=0.008)
the trabecular number was (0.742±0.112) mm-1 (P=0.014)
the trabecular thickness was (0.175±0.008) mm (P=0.005)
and the trabecular separation was (1.402±0.507) mm (P=0.022). Histological results showed that the new bone had a complete structure
with clear layers
as dense lamellar bone
and uniform bone matrix and bone lacunae. Conclusion: The exosomes derived from HucMSCs can promote the proliferation and osteogenic differentiation of BMSCs
and have the ability to repair osteoporotic bone defects.
Identification and validation of circulating exosome-derived microRNAs for the early diagnosis of gastric cancer
Research advances in mesenchymal stem cells and their exosomes in treatment of premature ovarian insufficiency
Advances in the clinical treatment of osteoporotic vertebral compression fractures
Research advances in liquid biopsy for bladder cancer
Related Author
Li Yan
Yang Liu
Zhang Yong
Liu Yongyu
Li Zongxin
Han Hongyan
Deng Kun
Zhang Yaodong
Related Institution
Key Laboratory of Ministry of Education for Biorheological Science and Technology,School of Bioengineering,Chongqing University
Department of Laboratory Medicine,The Third Affiliated Hospital of Chongqing Medical University
Center for Reproductive Medicine,Department of Obstetrics and Gynecology,Peking University Third Hospital; State Key Laboratory of Female Fertility Promotion;National Clinical Research Center for Obstetrics and Gynecology;Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology
Department of Orthopedic Surgery,Qilu Hospital of Shandong University
Department of Orthopedics Surgery,West China Hospital, Sichuan University